Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.

Identifieur interne : 002805 ( PubMed/Corpus ); précédent : 002804; suivant : 002806

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.

Auteurs : Stefan H E. Kaufmann ; Andrew J. Mcmichael

Source :

RBID : pubmed:15812488

English descriptors

Abstract

Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.

DOI: 10.1038/nm1221
PubMed: 15812488

Links to Exploration step

pubmed:15812488

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</title>
<author>
<name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H E" last="Kaufmann">Stefan H E. Kaufmann</name>
<affiliation>
<nlm:affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcmichael, Andrew J" sort="Mcmichael, Andrew J" uniqKey="Mcmichael A" first="Andrew J" last="Mcmichael">Andrew J. Mcmichael</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15812488</idno>
<idno type="pmid">15812488</idno>
<idno type="doi">10.1038/nm1221</idno>
<idno type="wicri:Area/PubMed/Corpus">002805</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002805</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</title>
<author>
<name sortKey="Kaufmann, Stefan H E" sort="Kaufmann, Stefan H E" uniqKey="Kaufmann S" first="Stefan H E" last="Kaufmann">Stefan H E. Kaufmann</name>
<affiliation>
<nlm:affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcmichael, Andrew J" sort="Mcmichael, Andrew J" uniqKey="Mcmichael A" first="Andrew J" last="Mcmichael">Andrew J. Mcmichael</name>
</author>
</analytic>
<series>
<title level="j">Nature medicine</title>
<idno type="ISSN">1078-8956</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS Vaccines</term>
<term>Acquired Immunodeficiency Syndrome (complications)</term>
<term>Acquired Immunodeficiency Syndrome (immunology)</term>
<term>Acquired Immunodeficiency Syndrome (prevention & control)</term>
<term>Animals</term>
<term>Clinical Trials as Topic (legislation & jurisprudence)</term>
<term>Humans</term>
<term>Mycobacterium bovis (genetics)</term>
<term>Mycobacterium bovis (immunology)</term>
<term>Mycobacterium tuberculosis (genetics)</term>
<term>Mycobacterium tuberculosis (immunology)</term>
<term>Tuberculosis (complications)</term>
<term>Tuberculosis (immunology)</term>
<term>Tuberculosis (prevention & control)</term>
<term>Tuberculosis Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>AIDS Vaccines</term>
<term>Tuberculosis Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Acquired Immunodeficiency Syndrome</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Acquired Immunodeficiency Syndrome</term>
<term>Mycobacterium bovis</term>
<term>Mycobacterium tuberculosis</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en">
<term>Clinical Trials as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Acquired Immunodeficiency Syndrome</term>
<term>Tuberculosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15812488</PMID>
<DateCompleted>
<Year>2005</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1078-8956</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>11</Volume>
<Issue>4 Suppl</Issue>
<PubDate>
<Year>2005</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.</ArticleTitle>
<Pagination>
<MedlinePgn>S33-44</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections--more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaufmann</LastName>
<ForeName>Stefan H E</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Max Planck Institute for Infection Biology, Department of Immunology, Schumannstrasse 21-22, 10117 Berlin, Germany. kaufmann@mpiib-berlin.mpg.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McMichael</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D032581">Tuberculosis Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Nat Med. 2005 May;11(5):578</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D016915" MajorTopicYN="Y">AIDS Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009163" MajorTopicYN="N">Mycobacterium bovis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D032581" MajorTopicYN="Y">Tuberculosis Vaccines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>125</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15812488</ArticleId>
<ArticleId IdType="pii">nm1221</ArticleId>
<ArticleId IdType="doi">10.1038/nm1221</ArticleId>
<ArticleId IdType="pmc">PMC7095892</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Clin Immunol. 2004 Jan;110(1):2-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14986673</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2002 Aug;8(8):843-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12141971</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2000 Jan;181(1):406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10608800</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>AIDS. 2003 Jul 4;17(10):1513-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12824789</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 1994 Mar 2;271(9):698-702</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8309034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2004 Mar;5(3):233-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2000 Sep 28;407(6803):523-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11029005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Bacteriol. 2002 Dec;184(24):6760-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12446625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 1996 Aug;2(8):893-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8705859</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2001 Feb;107(3):341-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11160158</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2003 Dec;1(3):181-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15035022</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Immunol. 2001 Oct;1(1):20-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11905811</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2002 May 6;20(15):1945-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11983251</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2002 Jan 17;415(6869):331-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11797011</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2003 Jan 15;187(2):315-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12552458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12644702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1999 Jan;73(1):797-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9847391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1991 Jun 6;351(6326):479-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2046750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Genet. 2001 Dec;2(12):967-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11733749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2001 Feb;69(2):1142-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11160012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1999 Nov 4;402(6757):79-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10573420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Sep;10(9):935-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15300244</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2002 May 2;417(6884):95-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11986671</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2004 Sep;5(9):927-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15300249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2003 May;9(5):533-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12692540</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2004 Mar 26;303(5666):2019-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15044802</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2001 Apr;69(4):2714-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11254639</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Mar;78(6):3140-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14990733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Tissue Antigens. 2004 Sep;64(3):251-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15304005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2001 Apr 6;292(5514):69-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11393868</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Microbiol. 2002 Jan;10(1):45-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11755085</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Immunol. 1996 Sep;26(9):2062-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8814247</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 1992 Apr;60(4):1263-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1312514</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Mar;10(3):229-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14991039</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2000 Oct;6(10):1140-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11017146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13853-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11095745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2002 May 10;296(2):338-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12069532</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 1998 Apr;4(4):397-402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9546783</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2004 Dec;4(12):761-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15567126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 2004 Dec 6;200(11):1455-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15583017</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2001 Jul 12;412(6843):190-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11449276</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1998 Jun 4;393(6684):474-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9624003</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12617573</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2002 Jun 22;359(9324):2177-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12090997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Microbiol. 2001 Jul;41(1):179-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11454210</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2004 Nov;72(11):6622-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15501795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 1996 Mar;2(3):334-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8612234</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1998 Jun 18;393(6686):705-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9641684</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1500-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15602129</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Dec;10(12):1359-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15568033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 1999 May 28;284(5419):1520-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10348738</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2005 May 31;23(29):3753-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15893612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 2004 Sep 20;200(6):749-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15365096</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2000 Sep;6(9):955-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10973302</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 1998 May;4(5 Suppl):515-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9585202</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2004 Jun 15;172(12):7618-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15187142</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2001 May;69(5):2773-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11292688</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5299-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9560270</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2002 Jan 17;415(6869):335-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11797012</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2001 Feb;69(2):681-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11159955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 1993 Dec 1;178(6):2249-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7504064</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2002 Mar 22;295(5563):2255-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11910108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):934-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8570663</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10685-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15243159</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 1994 Aug;12(11):1032-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7975844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11416222</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 1998 Mar;16(5):439-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9491498</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2000 Jun 9;288(5472):1789-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10846155</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 1996 Aug 9;86(3):367-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8756719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr HIV Res. 2004 Jul;2(3):223-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15279586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 1993 Dec 1;178(6):2243-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8245795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15131-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14627745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2004 Sep;72(9):5315-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15322028</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2004 May 28;304(5675):1318-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15166379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>AIDS. 2001 Feb;15 Suppl 1:S10-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11293384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Immunol. 1997;15:271-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9143689</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S353-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2652252</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2003 Oct;4(10):949-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14515128</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1999 Jul 15;400(6741):269-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10421369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2004 Dec;2(12):946-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15550940</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Mar;10(3):275-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14966520</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2000 Aug 17;406(6797):735-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10963599</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Immunol. 2004 Aug;4(8):630-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15286729</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2000 Oct 20;290(5491):486-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11039923</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Exp Immunol. 2001 Feb;123(2):264-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11207657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2002 Nov 28;420(6914):434-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12459786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2004 May 28;304(5675):1314-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15166378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Immunol. 2002;20:581-620</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11861613</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2003 Oct;4(10):939-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14515123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 2003 Sep 1;198(5):705-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12953092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 1999 Oct 14;341(16):1174-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10519895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 1999 Dec 4;354(9194):1932-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10622295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2003 Oct;4(10):1009-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14502286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 1998 Nov 1;102(9):1758-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9802890</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2002 Apr 1;168(7):3477-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11907108</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Nov;10(11):1240-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15502839</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Exp Immunol. 2000 Jan;119(1):92-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10606969</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2272-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8637862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2003 Jun;9(6):729-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12766765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2003 Apr 11;300(5617):337-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690201</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Immunol. 2002 Nov 1;169(9):5347-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12391256</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Med. 2002;53:557-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11818490</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Immun. 2004 Nov;72(11):6471-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15501778</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Pharm Biotechnol. 2003 Feb;4(1):69-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12570683</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Mar;10(3):221-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14991035</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Exp Med. 2003 Dec 15;198(12):1909-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14676302</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 1992 Dec 18;258(5090):1938-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1470917</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pathol. 2004 Oct;204(2):217-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15376257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2002 May 24;296(5572):1439-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12029127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002805 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002805 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:15812488
   |texte=   Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:15812488" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021